von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome
Miha Furlan(University Hospital of Bern), Bernhard Lämmle(University Hospital of Bern), Max Solenthaler(University Hospital of Bern), V. Aumann(University Hospital Magdeburg), Rodolfo Robles(University Hospital of Bern), Paul A. Kyrle(Karl Landsteiner Society), U. Mittler(University Hospital Magdeburg), I. Scharrer(Goethe University Frankfurt), Manuela Krause(Goethe University Frankfurt), Giuseppe Remuzzi(Mario Negri Institute for Pharmacological Research), B. Brenner(Vienna General Hospital), Miriam Galbusera(Mario Negri Institute for Pharmacological Research)
Cited by 1,665
Related Papers
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
|New England Journal of Medicine|2021|2.3k
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
|New England Journal of Medicine|2013|990
Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria
|The Lancet|1999|909
Overview of Complement Activation and Regulation
|Seminars in Nephrology|2013|864
High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism
|New England Journal of Medicine|2000|764